Bioventix (LON:BVXP) Hits New 12-Month Low – What’s Next?

Bioventix PLC (LON:BVXPGet Free Report) shares hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 1,450 and last traded at GBX 1,525, with a volume of 7868 shares traded. The stock had previously closed at GBX 1,525.

Bioventix Stock Down 3.7%

The company has a market cap of £75.45 million, a price-to-earnings ratio of 10.08 and a beta of 0.53. The firm has a 50 day moving average price of GBX 1,716.98 and a two-hundred day moving average price of GBX 2,018.40.

About Bioventix

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Featured Articles

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.